Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adria Laboratories
Columbus, Ohio, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Adria Laboratories was a U.S.-based pharmaceutical company with a strong focus on oncology and neurology therapeutics. It developed and marketed several drugs, including those for cancer treatment. The company was known for its research facilities in Columbus, Ohio, and had clinical involvement in studies such as the use of cabergoline for Parkinson's disease[4]. It operated as a subsidiary of Erbamont Inc., before being acquired.
- Therapeutic areas
- NeurologyOncology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on Adria Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adria Laboratories.